Search
for
Sort by
Research 331–360 of 529
- Hair follicle immune privilege and its collapse in alopecia areata
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Alopecia Areata: An Updated Review for 2023
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- JAK Inhibitors for Treatment of Alopecia Areata
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Alopecia Areata: Current Treatments and New Directions
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Resident Memory T Cells in Autoimmune Skin Diseases
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- PROTACs: A novel strategy for cancer drug discovery and development
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Granzyme B in Autoimmune Skin Disease
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Immunomodulatory Potential and Biocompatibility of Chitosan–Hydroxyapatite Biocomposites for Tissue Engineering
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis